United Therapeutics CFO Executes $5.7 Million Stock Sale Under Pre-Arranged Plan
James Edgemond, serving as the Chief Financial Officer and Treasurer for United Therapeutics Corp. (NASDAQ:UTHR), has completed a significant sale of company stock. On May 7, 2026, Edgemond sold 10,000 shares of common stock, generating total proceeds of $5,785,775. The transaction occurred within a specific price range, with individual shares sell…